• 1
    Blumberg BS, Alter HJ, Visnich S. A “new” antigen in leukemia sera. JAMA 1965;191:541546.
  • 2
    Alter HJ, Blumberg BS. Further studies on a “new” human isoprecipitin system (Australia antigen). Blood 1966;27:297309.
  • 3
    Alter HJ. Obituary: Baruch Blumberg. Nat Med 2011;473:155.
  • 4
    Walsh JH, Purcell RH, Morrow AG, Chanock RM, Schmidt PJ, Posttransfusion hepatitis after open-heart operations. JAMA 1970;211:261265.
  • 5
    Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG, Schmidt PJ. Posttransfusion hepatitis after exclusion of the commercial and hepatitis B antigen positive donor. Ann Int Med 1972;77:691699.
  • 6
    Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 1973;182:10261028.
  • 7
    Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975;292:767770.
  • 8
    Alter HJ, Purcell RH, Holland PV, Popper H. Transmissible agent in “non-A, non-B” hepatitis. Lancet 1978;1:459463.
  • 9
    Tabor E, Gerety RJ, Drucker JA, Seeff LB, Hoofnagle JH, Jackson DR, et al. Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1978;1:463466.
  • 10
    Feinstone SM, Mihalik KB, Kamimura J, Alter HJ, London WT, Purcell RH. Inactivaton of hepatitis B virus and non-A, non-B virus by chloroform. Infect Immun 1983;4:816821.
  • 11
    He L-F, Alling DW, Popkin TJ, Shapiro M, Alter HJ, Purcell RH. Determining the size of non-A, non-B hepatitis virus by filtration. J Inf Dis 1987;156:636640.
  • 12
    Berman MD, Alter HJ, Ishak KG, Purcell RH, Jones EA. The chronic sequelae of non-A, non-B hepatitis. Ann Int Med 1979;91:16.
  • 13
    Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol, DE. The relationship of donor transaminase (ALT) to recipient hepatitis: Impact on blood transfusion services. JAMA 1981;246:630634.
  • 14
    Aach RD, Szmuness W, Mosley JW, Hollinger FB, Khan RA, Stevens CE, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the transfusion-transmitted virus study. N Engl J Med 1981;304:989994.
  • 15
    Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcel RH, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488495.
  • 16
    Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Khan R, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Virus Study. Ann Intern Med 1984;101:733738.
  • 17
    Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359362.
  • 18
    Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kou, G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New Engl J Med 1989;321:14941500.
  • 19
    Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000;288:339344.
  • 20
    Farci P, Wollenberg K, Diaz G, Engle RE, Lai ME, Klenerman P, et al. Profibrinogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. PNAS 2012;109:1456214567.
  • 21
    Allison RD, Cantilena CC, Koziol D, Schechterly CS, Ness MD, Gibble J, et al. A 25-year retrospective-prospective study of the clinical and histologic outcomes of HCV infection and its modes of transmission in a cohort of initially asymptomatic blood donors. JID 2012;206:654661.